glp-1 drugs and anesthesia medications safe to continue before surgery in patients with diabetes obesity aGLP-1 receptor agonists & anesthesia:
Description
The move could significantly expand access to these treatments for people with diabetes and obesity.
FDA Enforcement Actions and Safety Concerns In September 2025, the FDA issued over 50 warning letters to compounders marketing GLP-1 products as generic equivalents to FDA-approved drugs
Gastric ultrasound identifies increased residual gastric contents in patients on GLP-1 receptor agonists, showing that shorter drug withholding and fasting times are linked to higher aspiration risk before anesthesia.
A new era for weight loss
